MEDICUS PHARMA LTD. (MDCX)
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
Plains All American Pipeline and Plains GP Holdings Provide Updated Capital Spending Guidance for 2026
Immuneering Appoints Andrew Gengos as Chief Financial Officer
Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company
Anfield Energy Announces a Key Milestone in Equipment Procurement, Advancing the Company Towards Hub-and-Spoke Production
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy Back Notice
General Announcement: Overseas Regulatory Announcement
General Announcement: Overseas Regulatory Announcement